CY1358A - Antimycotic agent with a high release of active compounds, in the form of a cream - Google Patents

Antimycotic agent with a high release of active compounds, in the form of a cream Download PDF

Info

Publication number
CY1358A
CY1358A CY135884A CY135884A CY1358A CY 1358 A CY1358 A CY 1358A CY 135884 A CY135884 A CY 135884A CY 135884 A CY135884 A CY 135884A CY 1358 A CY1358 A CY 1358A
Authority
CY
Cyprus
Prior art keywords
appropriate
reacted
bifonazole
diluent
imidazole
Prior art date
Application number
CY135884A
Other languages
English (en)
Inventor
Adams Karlheinz
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of CY1358A publication Critical patent/CY1358A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
CY135884A 1983-03-30 1984-03-29 Antimycotic agent with a high release of active compounds, in the form of a cream CY1358A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19833311701 DE3311701A1 (de) 1983-03-30 1983-03-30 Antimykotische mittel mit hoher wirkstoff-freisetzung in form von creme

Publications (1)

Publication Number Publication Date
CY1358A true CY1358A (en) 1987-08-07

Family

ID=6195162

Family Applications (1)

Application Number Title Priority Date Filing Date
CY135884A CY1358A (en) 1983-03-30 1984-03-29 Antimycotic agent with a high release of active compounds, in the form of a cream

Country Status (19)

Country Link
JP (1) JPS59184106A (en])
KR (1) KR840008284A (en])
AU (1) AU564956B2 (en])
BE (1) BE899278A (en])
CA (1) CA1212327A (en])
CH (1) CH660126A5 (en])
CY (1) CY1358A (en])
DE (1) DE3311701A1 (en])
ES (3) ES8503947A1 (en])
FR (1) FR2543435B1 (en])
GB (1) GB2137091B (en])
GR (1) GR81485B (en])
IT (1) IT1173761B (en])
KE (1) KE3704A (en])
LU (1) LU85271A1 (en])
PH (1) PH20420A (en])
PT (1) PT78313B (en])
SE (1) SE8401748L (en])
ZA (1) ZA842337B (en])

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5087620A (en) * 1990-05-17 1992-02-11 Bristol-Myers Squibb Co. Controlled dermal penetration enhancement using imidazoles
MX9303406A (es) * 1992-06-08 1994-01-31 Schering Plough Healthcare Composiciones estables anti-fungales de imidazol en polvo.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2461406C2 (de) * 1974-12-24 1984-06-14 Bayer Ag, 5090 Leverkusen Azolyl-(1)-methane und deren Salze, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel
DE3045914A1 (de) * 1980-12-05 1982-07-22 Bayer Ag, 5090 Leverkusen Antimykotische mittel mit hoher wirkstoff-freisetzung in form von elastischen fluessig-pflastern
DE3045913A1 (de) * 1980-12-05 1982-07-08 Bayer Ag, 5090 Leverkusen Antimykotische mittel mit hoher wirkstoff-freisetzung
DE3045915A1 (de) * 1980-12-05 1982-07-08 Bayer Ag, 5090 Leverkusen Antimykotische mittel mit hoher wirkstoff-freisetzung in form von elastischen fluessig-pflastern
DE3106635A1 (de) * 1981-02-23 1982-09-09 Bayer Ag Antimykotisches mittel mit hoher wirkstoff-freisetzung in form von stiften

Also Published As

Publication number Publication date
SE8401748L (sv) 1984-10-01
BE899278A (fr) 1984-10-01
KE3704A (en) 1987-03-27
FR2543435B1 (fr) 1988-06-17
ES8601693A1 (es) 1985-11-16
AU2623684A (en) 1984-10-04
ZA842337B (en) 1984-11-28
GB8408067D0 (en) 1984-05-10
SE8401748D0 (sv) 1984-03-29
CA1212327A (en) 1986-10-07
LU85271A1 (de) 1984-11-14
GB2137091A (en) 1984-10-03
ES539289A0 (es) 1985-11-16
FR2543435A1 (fr) 1984-10-05
PH20420A (en) 1987-01-05
ES530846A0 (es) 1985-04-16
KR840008284A (ko) 1984-12-14
ES8601692A1 (es) 1985-11-16
IT8420303A0 (it) 1984-03-29
DE3311701A1 (de) 1984-10-04
JPS59184106A (ja) 1984-10-19
GR81485B (en]) 1984-12-11
CH660126A5 (de) 1987-03-31
GB2137091B (en) 1986-10-01
PT78313A (en) 1984-04-01
PT78313B (en) 1986-06-02
AU564956B2 (en) 1987-09-03
ES539290A0 (es) 1985-11-16
ES8503947A1 (es) 1985-04-16
IT1173761B (it) 1987-06-24

Similar Documents

Publication Publication Date Title
CA1228812A (en) Process for the manufacture of novel topically administrable pharmaceutical compositions
JP3008131B2 (ja) グリセリンから誘導される非イオン両親媒性化合物、その調製方法、相応する中間体化合物及び前記化合物を含有する組成物
JP3043410B2 (ja) 水中油型エマルジョン
NL193216C (nl) Diethylammonium-2-(2,6-dichlooranilino)-fenylacetaat en topicaal toepasbaar preparaat dat het bevat.
US4457938A (en) Antimycotic agent, in the form of sticks, with a high release of active compound
US4348415A (en) Cosmetic and emulsifier compositions
JPH0380775B2 (en])
EP0084341B2 (en) Emulsion-type composition for external use
EP0025654A2 (en) A water-in-oil type cosmetic composition and an emulsifier composition
CY1358A (en) Antimycotic agent with a high release of active compounds, in the form of a cream
CA1212328A (en) Antimycotic agents with a high release of active compound, in the form of a solution and spray
EP0131790A2 (de) Etofenamat-Zubereitung
CA1209916A (en) Antimycotic agents in the form of gel systems with high release of active compound
DE69319589T2 (de) Juckreizstillendes mittel
KR950003611B1 (ko) 항진균 외용 이미다졸 제제
AP197A (en) Pharmaceutical formulations for treatment of virus infections of the skin containing penciclovir.
JP2000237570A (ja) 乳化剤
EP0383162A1 (de) Verwendung einer Wirkstoffkombination zur Behandlung rheumatischer Erkrankungen
KR100517728B1 (ko) 토코페롤 3중 안정화 화장료 조성물 및 그 제조 방법
FR2544198A1 (fr) Compositions pharmaceutiques topiques a base d'acide meclophenamique
NZ208693A (en) Formulations of etofenamate:2-(2-hydroxyethoxy)-ethyl n-(alpha,alpha,alpha-trifluoro-m-tolyl)anthranilate
EP0128459A2 (de) Antimykotische Mittel für einmalige gynäkologische Behandlung
JPH09309827A (ja) 抗真菌外用剤
FR2736639A1 (fr) Nouveaux composes hydrofluorocarbones a fonction thioester, procede de preparation, utilisations et compositions les comprenant
CZ282830B6 (cs) Léčivá mast bez dráždivého účinku na kůži a způsob její přípravy